Table 4.

Severe adverse events reported in double (cases) and single (control subjects) kidney recipients up to 6-mo follow-up

Adverse EventCasesControl Subjects
Urinary tract fistula41
Sepsis from urinary tract22
Deep vein thrombosis11
Hematoma10
Cytomegalovirus infection23
Gastrointestinal bleeding10
Bowel occlusion01
Angina/angioplasty01
Lung cancer01